Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jutta Bergler-Klein

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Medicine|January 8, 2025
His108Arg Transthyretin Amyloidosis-Shedding Light on a Distinctively Malignant VariantChristina Binder, Lena Marie Schmid, Christina Kronberger, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 6, 2024
Health-related quality of life is an independent predictor of mortality and hospitalisations in transthyretin amyloid cardiomyopathy: a prospective cohort studyMichael Poledniczek, Christina Kronberger, Robin Willixhofer, et al.
Cancers|June 12, 2026
Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological MalignanciesKalliopi Keramida, Marianne C Aznar, Jutta Bergler-Klein, et al.
European Journal of Clinical Investigation|December 3, 2024
Impact of oncologic diseases on outcome in patients with severe isolated tricuspid regurgitationVarius Dannenberg, Flora Zschocke, Kseniya Halavina, et al.
ESC Heart Failure|December 21, 2018
Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'Markus S Anker, Alessia Lena, Sara Hadzibegovic, et al.
Journal of Clinical Medicine|May 14, 2025
Cardiopulmonary Exercise Testing Correlates with Quantitative Left Ventricular [<sup>99m</sup>Tc]-DPD Uptake in Transthyretin Amyloid CardiomyopathyNikita Ermolaev, René Rettl, Robin Willixhofer, et al.
ESC Heart Failure|July 3, 2020
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AFSergio J Dubner, Christine Teutsch, Menno V Huisman, et al.
Reviews in Cardiovascular Medicine|March 31, 2025
Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac AmyloidosisNikita Ermolaev, Robin Willixhofer, Christoph Krall, et al.
European Radiology|July 16, 2025
Serial extracellular volume quantification using cardiac magnetic resonance imaging in transthyretin amyloidosis patients treated with tafamidisFranz Duca, Michael Poledniczek, Christina Kronberger, et al.
European Journal of Heart Failure|March 31, 2026
Insights into the renin-angiotensin-aldosterone system in transthyretin amyloid cardiomyopathyChristina Kronberger, Oliver Domenig, Noemi Pavo, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|January 8, 2025
His108Arg Transthyretin Amyloidosis-Shedding Light on a Distinctively Malignant VariantChristina Binder, Lena Marie Schmid, Christina Kronberger, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 6, 2024
Health-related quality of life is an independent predictor of mortality and hospitalisations in transthyretin amyloid cardiomyopathy: a prospective cohort studyMichael Poledniczek, Christina Kronberger, Robin Willixhofer, et al.
Cancers|June 12, 2026
Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological MalignanciesKalliopi Keramida, Marianne C Aznar, Jutta Bergler-Klein, et al.
European Journal of Clinical Investigation|December 3, 2024
Impact of oncologic diseases on outcome in patients with severe isolated tricuspid regurgitationVarius Dannenberg, Flora Zschocke, Kseniya Halavina, et al.
ESC Heart Failure|December 21, 2018
Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'Markus S Anker, Alessia Lena, Sara Hadzibegovic, et al.
Journal of Clinical Medicine|May 14, 2025
Cardiopulmonary Exercise Testing Correlates with Quantitative Left Ventricular [<sup>99m</sup>Tc]-DPD Uptake in Transthyretin Amyloid CardiomyopathyNikita Ermolaev, René Rettl, Robin Willixhofer, et al.
ESC Heart Failure|July 3, 2020
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AFSergio J Dubner, Christine Teutsch, Menno V Huisman, et al.
Reviews in Cardiovascular Medicine|March 31, 2025
Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac AmyloidosisNikita Ermolaev, Robin Willixhofer, Christoph Krall, et al.
European Radiology|July 16, 2025
Serial extracellular volume quantification using cardiac magnetic resonance imaging in transthyretin amyloidosis patients treated with tafamidisFranz Duca, Michael Poledniczek, Christina Kronberger, et al.
European Journal of Heart Failure|March 31, 2026
Insights into the renin-angiotensin-aldosterone system in transthyretin amyloid cardiomyopathyChristina Kronberger, Oliver Domenig, Noemi Pavo, et al.
Pageof 12